{"id":"https://openalex.org/W1992030745","doi":"https://doi.org/10.1371/journal.pone.0108887","title":"Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models","display_name":"Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models","alternate_titles":[],"publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W1992030745","doi":"https://doi.org/10.1371/journal.pone.0108887","mag":"1992030745","pmid":"https://pubmed.ncbi.nlm.nih.gov/25272271","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4182759"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0108887","doi":"https://doi.org/10.1371/journal.pone.0108887","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0108887","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0108887&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1992030745"],"child_works_count":13,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0108887&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070875375","display_name":"Glen M. Boyle","orcid":"https://orcid.org/0000-0002-1385-529X","observed_orcids":["https://orcid.org/0000-0002-1385-529X"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Glen M. Boyle","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109975164","display_name":"Marjorie M. A. D'Souza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marjorie M. A. D'Souza","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, University of Queensland, Brisbane, Queensland, Australia","Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","School of Medicine, University of Queensland, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, University of Queensland, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I217937681"]},{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"School of Medicine, University of Queensland, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072113767","display_name":"Carly J. Pierce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carly J. Pierce","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111952025","display_name":"Ryan A. Adams","orcid":"https://orcid.org/0000-0001-5602-3971","observed_orcids":["https://orcid.org/0000-0001-5602-3971"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]},{"id":"https://openalex.org/I2801814493","display_name":"Princess Alexandra Hospital","ror":"https://ror.org/04mqb0968","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I2801814493","https://openalex.org/I4210089726"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ryan A. Adams","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, University of Queensland, Brisbane, Queensland, Australia; Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia","Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia","Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","School of Medicine, University of Queensland, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, University of Queensland, Brisbane, Queensland, Australia; Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I217937681","https://openalex.org/I2801814493"]},{"raw_affiliation_string":"Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I2801814493"]},{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"School of Medicine, University of Queensland, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076386158","display_name":"Aaron S Cantor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aaron S. Cantor","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002835343","display_name":"Jenny\u2005P. Johns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jenny P. Johns","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076131019","display_name":"Lidia A. Maslovskaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lidia Maslovskaya","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066677550","display_name":"Victoria Gordon","orcid":"https://orcid.org/0000-0002-7637-6165","observed_orcids":["https://orcid.org/0000-0002-7637-6165"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Victoria A. Gordon","raw_affiliation_strings":["QBiotics Ltd., Yungaburra, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QBiotics Ltd., Yungaburra, Queensland, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052152759","display_name":"Paul\u2005W. Reddell","orcid":"https://orcid.org/0000-0002-0993-8957","observed_orcids":["https://orcid.org/0000-0002-0993-8957"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul W. Reddell","raw_affiliation_strings":["QBiotics Ltd., Yungaburra, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QBiotics Ltd., Yungaburra, Queensland, Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003544014","display_name":"Peter G. Parsons","orcid":"https://orcid.org/0000-0002-0473-3346","observed_orcids":["https://orcid.org/0000-0002-0473-3346"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter G. Parsons","raw_affiliation_strings":["Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery/Cancer Drug Mechanisms Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5070875375"],"corresponding_institution_ids":["https://openalex.org/I217937681"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":5.8868,"has_fulltext":true,"cited_by_count":110,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96470774,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"9","issue":"10","first_page":"e108887","last_page":"e108887"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.5800999999046326,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.5800999999046326,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.037700001150369644,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.026799999177455902,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-kinase-c-activators","display_name":"protein kinase C activators","score":0.7599999904632568},{"id":"https://openalex.org/keywords/intralesional-chemotherapy","display_name":"intralesional chemotherapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/skin-cancer","display_name":"skin cancer","score":0.7400000095367432},{"id":"https://openalex.org/keywords/tumor-ablation","display_name":"tumor ablation","score":0.8640000224113464},{"id":"https://openalex.org/keywords/diterpene-esters","display_name":"diterpene esters","score":0.890999972820282},{"id":"https://openalex.org/keywords/pkc-isoforms","display_name":"PKC isoforms","score":0.7559999823570251},{"id":"https://openalex.org/keywords/phorbol-myristate-acetate","display_name":"phorbol myristate acetate","score":0.9409999847412109},{"id":"https://openalex.org/keywords/respiratory-burst","display_name":"respiratory burst","score":0.7760000228881836},{"id":"https://openalex.org/keywords/hemorrhagic-necrosis","display_name":"hemorrhagic necrosis","score":0.8040000200271606},{"id":"https://openalex.org/keywords/tumor-vascular-permeability","display_name":"tumor vascular permeability","score":0.7820000052452087},{"id":"https://openalex.org/keywords/eschar-formation","display_name":"eschar formation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/tumor-cell-death","display_name":"cancer cell death","score":0.39500001072883606},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6313164234161377},{"id":"https://openalex.org/C2777314051","wikidata":"https://www.wikidata.org/wiki/Q27075304","display_name":"Bisindolylmaleimide","level":4,"score":0.602383017539978},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.5941236019134521},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5639753341674805},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.5195168256759644},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4354058504104614},{"id":"https://openalex.org/C2777295375","wikidata":"https://www.wikidata.org/wiki/Q609503","display_name":"Gliosarcoma","level":3,"score":0.41303086280822754},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.393240749835968},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.38526490330696106},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3606117367744446},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2968204617500305},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1740856170654297},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.13019955158233643},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.11144745349884033},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09682351350784302},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004224","descriptor_name":"Diterpenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004224","descriptor_name":"Diterpenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008301","descriptor_name":"Maleimides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011493","descriptor_name":"Protein Kinase C","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011493","descriptor_name":"Protein Kinase C","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015552","descriptor_name":"Injections, Intralesional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0108887","doi":"https://doi.org/10.1371/journal.pone.0108887","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0108887","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0108887&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3159329","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4182759","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4182759","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4182759/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:25272271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25272271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bb2e02be590046c3957ad6e86c353017","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/bb2e02be590046c3957ad6e86c353017","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 9, Iss 10, p e108887 (2014)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/1189708","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/_Intra_Lesional_Injection_of_the_Novel_PKC_Activator_EBC_46_Rapidly_Ablates_Tumors_in_Mouse_Models_/1189708","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.777.4747","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.777.4747","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/0a/9a/pone.0108887.PMC4182759.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0108887","doi":"https://doi.org/10.1371/journal.pone.0108887","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0108887","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0108887&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7876938939","display_name":"Taking a cancer drug towards a clinical trial","funder_award_id":"1017676","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320320984","display_name":"University of Queensland","ror":"https://ror.org/00rqy9422"},{"id":"https://openalex.org/F4320321995","display_name":"Queensland Government","ror":"https://ror.org/037405308"},{"id":"https://openalex.org/F4320331537","display_name":"Qbiotics","ror":null},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1992030745.pdf","grobid_xml":"https://content.openalex.org/works/W1992030745.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W54850491","https://openalex.org/W1546905222","https://openalex.org/W1911093385","https://openalex.org/W1988649727","https://openalex.org/W1990483259","https://openalex.org/W1994061582","https://openalex.org/W2000542448","https://openalex.org/W2004585452","https://openalex.org/W2006202974","https://openalex.org/W2007492166","https://openalex.org/W2011001118","https://openalex.org/W2033692560","https://openalex.org/W2035729386","https://openalex.org/W2044714045","https://openalex.org/W2048080111","https://openalex.org/W2051121992","https://openalex.org/W2055499537","https://openalex.org/W2060476962","https://openalex.org/W2067508471","https://openalex.org/W2097661119","https://openalex.org/W2102999763","https://openalex.org/W2107600426","https://openalex.org/W2109689528","https://openalex.org/W2114234134","https://openalex.org/W2117985944","https://openalex.org/W2120601121","https://openalex.org/W2121955821","https://openalex.org/W2129819037","https://openalex.org/W2134555179","https://openalex.org/W2157154128","https://openalex.org/W2179804124","https://openalex.org/W2253765481","https://openalex.org/W2319929006","https://openalex.org/W2416390620"],"related_works":["https://openalex.org/W2201791045","https://openalex.org/W2085642575","https://openalex.org/W4233888025","https://openalex.org/W6944112898","https://openalex.org/W1831284629","https://openalex.org/W2077620356","https://openalex.org/W2412959227","https://openalex.org/W2000542448","https://openalex.org/W2022076759","https://openalex.org/W1988278338"],"abstract_inverted_index":{"Intra-lesional":[0],"chemotherapy":[1],"for":[2,10,119,131],"treatment":[3,198],"of":[4,46,53,66,96,133,185,194,205,215,228,241,247],"cutaneous":[5],"malignancies":[6],"has":[7],"been":[8],"used":[9],"many":[11],"decades,":[12],"allowing":[13],"higher":[14],"local":[15,170],"drug":[16],"concentrations":[17],"and":[18,32,51,59,68,102,165,211,238],"less":[19,117],"toxicity":[20],"than":[21,123],"systemic":[22],"agents.":[23],"Here":[24],"we":[25],"describe":[26],"a":[27,64,92,224],"novel":[28],"diterpene":[29],"ester,":[30],"EBC-46,":[31],"provide":[33],"preclinical":[34],"data":[35],"supporting":[36],"its":[37],"use":[38],"as":[39],"an":[40,202],"intra-lesional":[41,175,226],"treatment.":[42],"A":[43],"single":[44,225],"injection":[45,146,176,179,227],"EBC-46":[47,71,90,114,158,186,229],"caused":[48],"rapid":[49,60,234],"inflammation":[50],"influx":[52],"blood,":[54],"followed":[55],"by":[56,83,147,189,201,212],"eschar":[57],"formation":[58],"tumor":[61,139,235],"ablation":[62],"in":[63,125,135,167,209,218,244],"range":[65],"syngeneic":[67],"xenograft":[69],"models.":[70],"induced":[72],"oxidative":[73],"burst":[74],"from":[75,153],"purified":[76],"human":[77],"polymorphonuclear":[78],"cells,":[79],"which":[80],"was":[81,128,159,187,199],"prevented":[82],"the":[84,106,163],"Protein":[85],"Kinase":[86],"C":[87],"inhibitor":[88],"bisindolylmaleimide-1.":[89,192],"activated":[91],"more":[93,129],"specific":[94],"subset":[95],"PKC":[97],"isoforms":[98],"(PKC-\u03b2I,":[99],"-\u03b2II,":[100],"-\u03b1":[101],"-\u03b3)":[103],"compared":[104,177],"to":[105],"structurally":[107],"related":[108],"phorbol":[109],"12-myristate":[110],"13-acetate":[111],"(PMA).":[112],"Although":[113],"showed":[115],"threefold":[116],"potency":[118],"inhibiting":[120],"cell":[121,207,236],"growth":[122],"PMA":[124],"vitro,":[126],"it":[127],"effective":[130],"cure":[132,240],"tumors":[134,217,243],"vivo.":[136,219],"No":[137],"viable":[138],"cells":[140],"were":[141],"evident":[142],"four":[143],"hours":[144],"after":[145],"ex":[148],"vivo":[149],"culture.":[150],"Pharmacokinetic":[151],"profiles":[152],"treated":[154,216],"mice":[155],"indicated":[156],"that":[157,223],"retained":[160],"preferentially":[161],"within":[162],"tumor,":[164],"resulted":[166],"significantly":[168],"greater":[169],"responses":[171],"(erythema,":[172],"oedema)":[173],"following":[174,197],"with":[178,191],"into":[180],"normal":[181],"skin.":[182],"The":[183],"efficacy":[184],"reduced":[188],"co-injection":[190],"Loss":[193],"vascular":[195],"integrity":[196],"demonstrated":[200],"increased":[203],"permeability":[204],"endothelial":[206],"monolayers":[208],"vitro":[210],"CD31":[213],"immunostaining":[214],"Our":[220],"results":[221],"demonstrate":[222],"causes":[230],"PKC-dependent":[231],"hemorrhagic":[232],"necrosis,":[233],"death":[237],"ultimate":[239],"solid":[242],"pre-clinical":[245],"models":[246],"cancer.":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1992030745","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
